Finally, we observed that high PDCL3 expression was associated with poor overall survival (OS, Figure 1C) and progression-free survival (PFS, Figure 1D) in eight different types of cancer, with the most significant relationship being glioma. The gene discussed is PDCL3; the disease is central nervous system cancer.